TrialJapanese journal of clinical oncology2018

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study.

Satoshi Fukasawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.